196 related articles for article (PubMed ID: 23490218)
1. Attitudes and practices with regard to circumcision in haemophilia patients in Southern Iran.
Haghpanah S; Ardeshiri R; Zahedi Z; Golzadeh MH; Silavizadeh S; Karimi M
Haemophilia; 2013 May; 19(3):e177-8. PubMed ID: 23490218
[No Abstract] [Full Text] [Related]
2. Prophylaxis in children with haemophilia - the Polish experience.
Klukowska A; Urasinski T; Janik-Moszant A; Bobrowska H; Balwierz W; Woznica-Karczmarz I; Dobaczewski G; Wlazlowski M; Koltan A; Badowska W; Dakowicz L; Karolczyk G; Kostrzewska M; Korczowski B; Wasinski D; Pietrys D; Laguna P; Wysocka M
Haemophilia; 2014 Jan; 20(1):e108-10. PubMed ID: 24251651
[No Abstract] [Full Text] [Related]
3. Maintenance of treatment logs by haemophilia patients.
du Treil S; Rice J; Leissinger CA
Haemophilia; 2010 May; 16(3):545-7. PubMed ID: 20050930
[No Abstract] [Full Text] [Related]
4. A single centre experience in circumcision of haemophilia patients: Izmir protocol.
Yilmaz D; Akin M; Ay Y; Balkan C; Celik A; Ergün O; Kavakli K
Haemophilia; 2010 Nov; 16(6):888-91. PubMed ID: 20491959
[TBL] [Abstract][Full Text] [Related]
5. How to manage invasive procedures in children with haemophilia.
Ljung RC; Knobe K
Br J Haematol; 2012 Jun; 157(5):519-28. PubMed ID: 22390160
[TBL] [Abstract][Full Text] [Related]
6. The natural history of mild haemophilia: a 30-year single centre experience.
Tagliaferri A; Di Perna C; Riccardi F; Pattacini C; Rivolta GF; Franchini M
Haemophilia; 2012 Mar; 18(2):166-74. PubMed ID: 21771207
[TBL] [Abstract][Full Text] [Related]
7. Clinical use of recombinant factor VIII Fc and recombinant factor IX Fc in patients with haemophilia A and B.
Wang C; Young G
Haemophilia; 2018 May; 24(3):414-419. PubMed ID: 29405496
[TBL] [Abstract][Full Text] [Related]
8. Describing the quality of life of boys with haemophilia in China: Results of a multicentre study using the CHO-KLAT.
Tang L; Xu W; Li CG; Hou F; Feng XQ; Wang H; Li XJ; Li WL; Liu JP; Sun LR; Wang SH; Jin J; Fang Q; Luke KH; Poon MC; Blanchette VS; Usuba K; Young NL; Wu R
Haemophilia; 2018 Jan; 24(1):113-119. PubMed ID: 28922525
[TBL] [Abstract][Full Text] [Related]
9. Prophylaxis in children with hemophilia: is it the optimal treatment?
Lusher JM
Thromb Haemost; 1997 Jul; 78(1):726-9. PubMed ID: 9198246
[No Abstract] [Full Text] [Related]
10. Current issues in prophylactic therapy for persons with hemophilia.
Dunn AL; Abshire TC
Acta Haematol; 2006; 115(3-4):162-71. PubMed ID: 16549891
[TBL] [Abstract][Full Text] [Related]
11. A comparison of coagulation factor replacement with and without prednisolone in the treatment of haematuria in haemophilia and Christmas disease.
Rizza CR; Kernoff PB; Matthews JM; McLennan CR; Rainsford SG
Thromb Haemost; 1977 Feb; 37(1):86-90. PubMed ID: 320712
[TBL] [Abstract][Full Text] [Related]
12. [Long-term low-dose secondary prophylaxis for severe and moderate hemophilia children with arthropathy in China: a single-center observation study].
Wu RH; Wu XY; Zhang NN; Zhao L; Zhang JS; Zhen YZ; Peng Y
Zhonghua Xue Ye Xue Za Zhi; 2013 Jul; 34(7):632-4. PubMed ID: 23906463
[No Abstract] [Full Text] [Related]
13. An analysis of factors affecting the incidence of inhibitor formation in patients with congenital haemophilia in Japan.
Shirahata A; Fukutake K; Higasa S; Mimaya J; Oka T; Shima M; Takamatsu J; Taki M; Taneichi M; Yoshioka A;
Haemophilia; 2011 Sep; 17(5):771-6. PubMed ID: 21682824
[TBL] [Abstract][Full Text] [Related]
14. A trial of prophylactic replacement therapy in haemophilia and Christmas disease.
Ramsay DM; Parker AC
J Clin Pathol; 1973 Apr; 26(4):243-7. PubMed ID: 4701794
[TBL] [Abstract][Full Text] [Related]
15. Cryoprecipitate in the management of haemophilia in Kenya.
Taylor JR; Ahluwalia NS; Morrison CJ; Kaviti JN; Cardwell CL
East Afr Med J; 1969 Feb; 46(2):121-8. PubMed ID: 5798053
[No Abstract] [Full Text] [Related]
16. [Principles of modern therapy for hemophilia A and B in childhood].
Ströder J; Ambs E
Dtsch Med Wochenschr; 1968 Mar; 93(12):539-41. PubMed ID: 5639667
[No Abstract] [Full Text] [Related]
17. Induction of immune tolerance in hemophiliacs with inhibitors by combined treatment with i.v. IgG, cyclophosphamide and factor VIII or IX.
Nilsson IM; Berntorp E
Prog Clin Biol Res; 1990; 324():69-78. PubMed ID: 2106694
[No Abstract] [Full Text] [Related]
18. Progress in the clinical management of haemophilia.
Bloom AL
Thromb Haemost; 1991 Jul; 66(1):166-77. PubMed ID: 1926047
[No Abstract] [Full Text] [Related]
19. Products for the treatment of hemophilia A and B prepared by ion exchange chromatography.
Sultan Y; Boyeldieu D; Stieltjes N
Nouv Rev Fr Hematol (1978); 1994; 36 Suppl 1():S59-60. PubMed ID: 8177717
[TBL] [Abstract][Full Text] [Related]
20. Treatment of patients with factor VIII and factor IX inhibitors with special focus on the use of recombinant factor VIIa.
Hedner U
Thromb Haemost; 1999 Aug; 82(2):531-9. PubMed ID: 10605747
[No Abstract] [Full Text] [Related]
[Next] [New Search]
